The market is dominated by domestic suppliers, as imports account for 7.1% of total market size in 2023. B2B drives market demand, with B2B spending representing 81.3% of total demand in 2023. India has the fourth largest market size for pharmaceuticals regionally, with demand reaching USD28.2 billion in 2023. Aurobindo Pharma Ltd is the largest company in India, generating 4.7% of the industry’s total production value in 2023. The industry is fragmented, with the top five companies generating 21.8% of total production value in 2023. The total number of companies increases in 2023, to 294,453 units. The costs of the industry increase by 2.3% in 2023, largely driven by rising B2B costs. The industry’s profitability decreases and stands at 19.5% of production value in 2023, the ninth highest regionally. The industry’s exports share increases in 2023 to 46.5% of total production output. With production value of USD45.2 billion, India accounts for 6.0% of the Asia Pacific total in 2023.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in India: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in India: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!